Chronic histiocytic intervillositis: Outcome, associated diseases and treatment in a multicenter prospective study
Authors:
- Nathalie Costedoat-ChalumeauNCNathalie Costedoat-Chalumeau
- Agathe MasseauAMAgathe Masseau
- Angela BottaABAngela Botta
- Anastasia ChudzinskiACAnastasia Chudzinski
- Arnaud TheulinATArnaud Theulin
- Virginie EmmanuelliVEVirginie Emmanuelli
- Eric HachullaEHEric Hachulla
- Sara De CarolisSCSara De Carolis
- Aurélie RevauxARAurélie Revaux
- Pascale NicaisePNPascale Nicaise
- Françoise CornelisFCFrançoise Cornelis
- 16 July 2014
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 48 (1) , 40-45
Abstract
Introduction: In this prospective multicenter study, we aimed to describe (1) the outcome of pregnancy in the case of previous chronic histiocytic intervillositis (CHI), (2) the immunological findings and associated diseases, (3) the treatments, and (4) the factors associated with pregnancy loss. We prospectively included all patients with a prior CHI with ongoing pregnancy between 2011 and 2013. Twenty-four women (age 34±5 years) were included in this study. An autoimmune disease was present in seven (29%) cases. Twenty-one prospective pregnancies were treated. The number of live births was more frequent comparatively to the previous obstetrical issues (16/24 versus 24/76; p=0.003). Most of the pregnancies were treated (88%), whereas only 13% of previous pregnancies were treated (p<0.05). No difference was found with respect to the pregnancy outcome in the different treatment regimens. In univariate analyses, a prior history of intrauterine death and intrauterine growth restriction and the presence of CHI in prospective placentas were associated with failure to have a live birth. In this multicenter study, we show the frequency of the associated autoimmune diseases in CHI, as well as the presence of autoantibodies without characterized autoimmune disease. The number of live births increased from 32% to 67% in the treated pregnancies. Despite the treatment intervention, the risk of preterm delivery remained at 30%. Last, we show that the recurrence rate of an adverse pregnancy outcome persisted at 30% despite treatment intervention. CHI is associated with high recurrence rate and the combined regimen seems to be necessary, in particular, in the presence of previous intrauterine death.Keywords
This publication has 16 references indexed in Scilit:
- Chronic histiocytic intervillositis of unknown etiology: Clinical features in a consecutive series of 69 casesPlacenta, 2011
- Chronic intervillositis of the placenta: A systematic reviewPlacenta, 2010
- Pathological characteristics of a series of rare chronic histiocytic intervillositis of the placentaPlacenta, 2010
- Chronic intervillositis of unknown etiology (CIUE): Relation between placental lesions and perinatal outcomeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Pronostic périnatal des grossesses compliquées d’intervillites chroniques placentairesJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2006
- Association des corticoïdes à l’aspirine pour la prévention des récidives de villite ou d’intervillite chroniques d’étiologie indéterminéeJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2006
- Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive lossHuman Pathology, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Massive chronic intervillositis associated with recurrent abortionsHuman Pathology, 1995
- Fibrinoid and Trophoblastic Necrosis With Massive Chronic Intervillositis: An Extreme Variant of Villitis of Unknown EtiologyAmerican Journal of Reproductive Immunology, 1987